Drug recalls
Every medicine recall reported to the FDA since 2012, newest first. Last checked for new ones 15 hours ago.
18,166 recalls
- Class II Prasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 0378-51… Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria Mylan Pharmaceuticals Inc · Sep 9, 2026 · Ongoing
- Class III Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intramuscular Use Only, Mfd. Failed Stability Specifications: Out of specification stability result for the protein concentration profile. Chiesi USA, Inc. · Sep 9, 2026 · Ongoing
- Class II 2% Chlorhexidine Gluconate* Cloth, Non-sterile, 6 Disposable cloths, Sage Products LLC, 3909 Three Oaks Road, Cary, Illinois 60013. NDC: 53462-705-26 Cross Contamination with Other Products Sage Products, LLC · Sep 9, 2026 · Ongoing
- Class II traZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured in Croatia By: Pliva Hrvatska d.o.o, Zagreb, Croatia, Manufactured For: Teva Pha… Presence of Foreign Tablets/Capsules Teva Pharmaceuticals USA, Inc · Sep 9, 2026 · Ongoing
- Class III Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufact… Failed dissolution specifications. Supernus Pharmaceuticals, Inc. · Sep 9, 2026 · Ongoing
- Class II Carton label: Mycophenolate Mofetil for injection, USP, 500 mg/vial, Sterile, 4 Single Dose Vials, Rx only, Manufactured for: Mylan Institutional LLC, Morgantow… Failed Dissolution Specifications Mylan Pharmaceuticals Inc · Sep 9, 2026 · Ongoing
- Class II Broadway Joe's Pain Cream, 3000 gm CBD, (Histamine Dihydrochloride 0.025%) (CDB Isolate 3000mg, HempSeed Oil 2000mg),4 oz-jar, Produced for Broadway Joe's, Fran… CGMP Deviations: Potential contamination of raw material Lexia LLC · Sep 9, 2026 · Ongoing
- Class II Broadway Joe's Pain Cream, (Histamine Dihydrochloride 0.025%), 1500mg CBD Isolate, 1000mg Hempseed oil, 2 oz-jar, Produced for Broadway Joe's, Franklin, TN, 370… CGMP Deviations: Potential contamination of raw material Lexia LLC · Sep 9, 2026 · Ongoing
- Class II THE ONE SPF 50 INVISIBLE SUNSCREEN GEL, (Avobenzone 3%, Homosalate 7%, Octocrylene 10%, Octisalate 5%), 90ml - 3 fl. oz. Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label. Allies Group Inc. · Sep 9, 2026 · Ongoing
- Class II THE ONE SPF 50 INVISIBLE SUNSCREEN GEL, (Avobenzone 3%, Homosalate 7%, Octocrylene 10%, Octisalate 5%), 20ml - 0.7 fl. oz. Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label. Allies Group Inc. · Sep 9, 2026 · Ongoing
- Class II THE ONE SPF 50 INVISIBLE SUNSCREEN GEL, (Avobenzone 3%, Homosalate 7%, Octocrylene 10%, Octisalate 5%), 3ml - 0.1 fl. Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label. Allies Group Inc. · Sep 9, 2026 · Ongoing
- Class II THE ONE SPF 50 INVISIBLE SUNSCREEN GEL, (Avobenzone 3%, Homosalate 7%, Octocrylene 10%, Octisalate 5%), 50ML - 1.7 fl. Subpotent Product: Firm Testing indicated the affected product may not reliably provide the SPF 50 protection stated on the label. Allies Group Inc. · Sep 9, 2026 · Ongoing
- Class III Doxylamine Succinate and Pyridoxine HCl Delayed-Release tablets 10 mg/10 mg, 100-count bottle, Rx Only, MADE IN INDIA, Distributed by: Bionpharma Inc., Princeto… Presence of Foreign Tablets/Capsules Bionpharma Inc. · Sep 9, 2026 · Ongoing
- Class II Daptomycin, in 0.9% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg/mL), 1,000 mg total, in 1000 mL Single Dose Container, Rx only, Sterile Nonpyrogenic,… CGMP Deviations Baxter Healthcare Corporation · Sep 9, 2026 · Ongoing
- Class II Vancomycin Injection, USP, in 0.9% Sodium Chloride, 1g per 200 mL (5 mg/mL) in GALAXY Single-Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Co… CGMP Deviations Baxter Healthcare Corporation · Sep 9, 2026 · Ongoing
- Class II Vasopressin, in 0.9% Sodium Chloride Injection, 40 units per 100 mL (0.4 units/mL), 100mL Single-Dose Container, Rx only, Sterile, Baxter Healthcare Corporation… CGMP Deviations Baxter Healthcare Corporation · Sep 9, 2026 · Ongoing
- Class II Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Manufactured by: Baxter… CGMP Deviations Baxter Healthcare Corporation · Sep 9, 2026 · Ongoing
- Class II Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Manufactured by: Baxter… CGMP Deviations Baxter Healthcare Corporation · Sep 9, 2026 · Ongoing
- Class II Clindamycin Phosphate in 0.9% Sodium Chloride Injection, 600 mg per 50 mL (12 mg/mL), 50 mL Single-Dose GALAXY Container, Rx only, Sterile Nonpyrogenic, Baxter… CGMP Deviations Baxter Healthcare Corporation · Sep 9, 2026 · Ongoing
- Class II Clindamycin Injection USP in 5% Dextrose, 900 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Co… CGMP Deviations Baxter Healthcare Corporation · Sep 9, 2026 · Ongoing